Search

Author/Creator Faje, Alexander

3. Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis. Issue 3 (September 2019)

Authors:
Faje, Alexander; Reynolds, Kerry; Zubiri, Leyre; Lawrence, Donald; Cohen, Justine V; Sullivan, Ryan J; Nachtigall, Lisa; Tritos, Nicholas
Journal:
European journal of endocrinology
Issue:
Volume 181:Issue 3(2019)
Page Start:
211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy. (21st November 2019)

Authors:
Zubiri, Leyre; Allen, Ian M.; Taylor, Martin S.; Guidon, Amanda C.; Chen, Steven T.; Schoenfeld, Sara R.; Neilan, Tomas G.; Sise, Meghan E.; Mooradian, Meghan J.; Rubin, Krista M.; Leaf, Rebecca Karp; Parikh, Aparna R.; Faje, Alexander; Gainor, Justin F.; Cohen, Justine V.; Fintelmann, Florian J....
Journal:
Oncologist
Issue:
Volume 25:Number 3(2020)
Page Start:
e398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗